Beaumont Financial Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $788K | Sell |
|
|||||
|
2025
Q2 | $793K | Buy |
|
|||||
|
2025
Q1 | $622K | Buy |
|
|||||
|
2024
Q4 | $630K | Sell |
|
|||||
|
2024
Q3 | $561K | Sell |
|
|||||
|
2024
Q2 | $794K | Buy |
|
|||||
|
2024
Q1 | $815K | Buy |
|
|||||
|
2023
Q4 | $650K | Buy |
|
|||||
|
2023
Q3 | $588K | Sell |
|
|||||
|
2023
Q2 | $988K | Buy |
|
|||||
|
2023
Q1 | $864K | Buy |
|
|||||
|
2022
Q4 | $778K | Sell |
|
|||||
|
2022
Q3 | $863K | Hold |
|
|||||
|
2022
Q2 | $994K | Buy |
|
|||||
|
2022
Q1 | $1.23M | Buy |
|
|||||
|
2021
Q4 | $560K | Hold |
|
|||||
|
2021
Q3 | $489K | Sell |
|
|||||
|
2021
Q2 | $551K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $212K | Buy |
|